Bringing the very best science and medicine to our best equine friends
April 2016

Kindred Biosciences to Announce First Quarter 2016 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, May 5, 2016 San Francisco, CA (April 25, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its first quarter 2016 financial results on May 5, 2016 after the market close. The Company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time that day. Interested parties may access the call by dialing toll-free (855) 433-0927 from the US, or (484) …

Continue Reading

Kindred Biosciences Elects Herbert D. Montgomery to Join Its Board of Directors

Highly Experienced Finance Executive to Join KindredBio’s Board San Francisco, CA (April 15, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Mr. Herbert Montgomery will be joining the Company’s Board of Directors.  Mr. Montgomery will serve as the Chairman of the Company’s Audit Committee. Mr. Montgomery has extensive experience in finance, including having served as CFO of several public companies, and having taken three companies public.  Most recently, he was Vice Chairman of the Board and Executive Officer of Lightpost Holdings, LLC. Prior to that, Mr. Montgomery …

Continue Reading